In Vitro Diagnostics (IVD) provides vital information to aid clinical decisions from diagnosis through treatment and prognosis.
It is key to ensuring that the right treatment is delivered to patients within critical timeframes.
Healthcare is speeding up and we are expected to do more with less. Rapid delivery of accurate lab tests, with consistent reliability and quality are vital to delivering improved patient outcomes and creating value for clinicians and healthcare executives.
Almost all countries in the Middle East and Africa provide public healthcare programs, complemented by private healthcare insurance. Public funding is commonly strained by health emergencies such as Covid-19 and by constantly increasing demand.
Public funding is commonly strained by health emergencies such as Covid-19 and by constantly increasing demand. Cost-containment and obtaining real value from interventions are therefore vital for sustaining our healthcare systems.
Value of Diagnostic Information (VODI) goes beyond conventional cost control as it crosses four categories of value: